|
English
|
正體中文
|
简体中文
|
2831195
|
|
???header.visitor??? :
33211256
???header.onlineuser??? :
940
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"ottesen lone harild"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 國立臺灣大學 |
2012 |
A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC).
|
Yau, Thomas Cheung; Sukeepaisarnjaroen, Wattana; Chao, Yee; Yen, Chia-Jui; Lausoontornsiri, Wirote; Chen, Pei-Jer; Sanpajit, Theeranun; Lencioni, Riccardo; Camp, Aaron C.; Cox, Donna S.; Kallender, Howard; Ottesen, Lone Harild; Poon, Ronnie Tung-Ping; 陳培哲 |
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
